Skip to main content
. 2021 Jul 7;11:362. doi: 10.1038/s41398-021-01487-4

Table 1.

Base–case scenario results.

General treatment schedule without HLA test HLA-guided treatment schedule
Cost per patient/10 years (JPN/UK) £16,487/£4211 £16,552/£4281
Incremental Cost (JPN/UK) £65/£70
Effect per patient/10 years (QALYs: JPN/UK) 6.22608/5.82665 6.22917/5.82990
Incremental effect (QALYs: JPN/UK) 0.00309/0.00326
ICER (JPN/UK) £21,024/£21,343

JPN Japan, UK United Kingdom, QALY quality-adjusted life years, ICER incremental cost-effectiveness ratio.